Obesity Reviews SCIE

國際簡稱：OBES REV 參考譯名：肥胖評論

主要研究方向：醫(yī)學(xué)-內(nèi)分泌學(xué)與代謝非預(yù)警期刊審稿周期：約1月

《肥胖評論》(Obesity Reviews)是一本由Wiley-Blackwell Publishing Ltd出版的以醫(yī)學(xué)-內(nèi)分泌學(xué)與代謝為研究特色的國際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評論文章和綜述文章，及時報道該領(lǐng)域相關(guān)理論、實踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本混合期刊，近三年沒有被列入預(yù)警名單。該期刊享有很高的科學(xué)聲譽，影響因子不斷增加，發(fā)行量也同樣高。

2區(qū) 中科院分區(qū)
Q1 JCR分區(qū)
125 年發(fā)文量
8 IF影響因子
混合是否OA
137 H-index
2000 創(chuàng)刊年份
Monthly 出版周期
English 出版語言

Obesity Reviews is a monthly journal publishing reviews on all disciplines related to obesity and its comorbidities. This includes basic and behavioral sciences, clinical treatment and outcomes, epidemiology, prevention and public health. The journal should, therefore, appeal to all professionals with an interest in obesity and its comorbidities. Review types may include systematic narrative reviews, quantitative meta-analyses and narrative reviews but all must offer new insights, critical or novel perspectives that will enhance the state of knowledge in the field. Prevalence studies that compare (review) trends across countries or regions or across ethnic groups or relevant subpopulations and provide novel insights and/or conclusions will be considered. The journal also invites short reviews presenting original or challenging theories, hypotheses or alternative interpretations of findings. Case reports presenting important and novel information and Letters to the Editor are also welcome. The journal will contribute to education and inter-professional developments by planning pro and con reviews on current controversies.

The editorial policy is to publish high quality peer-reviewed manuscripts that provide needed new insight into all aspects of obesity and its related comorbidities while minimizing the period between submission and publication.

Obesity Reviews is the official reviews journal of the World Obesity Federation. A special subscription rate is available for individuals who are members of their national associations under the umbrella of WO.

[ 查看全部 ]

投稿咨詢加急咨詢

Obesity Reviews期刊信息

ISSN：1467-7881
出版語言：English
是否OA：混合
E-ISSN：1467-789X
出版地區(qū)：ENGLAND
是否預(yù)警：否
出版商：Wiley-Blackwell Publishing Ltd
出版周期：Monthly
創(chuàng)刊時間：2000
開源占比：0.2819
Gold OA文章占比：40.18%
OA被引用占比：0.2760...
出版國人文章占比：0.09
出版撤稿占比：0
研究類文章占比：11.20%

Obesity Reviews CiteScore評價數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

19.3

2.818

2.798

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Public Health, Environmental and Occupational Health	Q1	8 / 665	98%
大類：Medicine 小類：Endocrinology, Diabetes and Metabolism	Q1	10 / 244	96%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個指標。當年CiteScore 的計算依據(jù)是期刊最近4年（含計算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻數(shù)。例如，2022年的 CiteScore 計算方法為：2022年的 CiteScore =2019-2022年收到的對2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻數(shù)量注：文獻類型包括：文章、評論、會議論文、書籍章節(jié)和數(shù)據(jù)論文。

Obesity Reviews中科院評價數(shù)據(jù)

中科院 2023年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	是	醫(yī)學(xué)	2區(qū)	ENDOCRINOLOGY & METABOLISM 內(nèi)分泌學(xué)與代謝	2區(qū)

中科院 2022年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	是	醫(yī)學(xué)	1區(qū)	ENDOCRINOLOGY & METABOLISM 內(nèi)分泌學(xué)與代謝	1區(qū)

中科院 2021年12月舊的升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	是	醫(yī)學(xué)	1區(qū)	ENDOCRINOLOGY & METABOLISM 內(nèi)分泌學(xué)與代謝	1區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	是	醫(yī)學(xué)	2區(qū)	ENDOCRINOLOGY & METABOLISM 內(nèi)分泌學(xué)與代謝	2區(qū)

中科院 2021年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	是	醫(yī)學(xué)	1區(qū)	ENDOCRINOLOGY & METABOLISM 內(nèi)分泌學(xué)與代謝	1區(qū)

中科院 2020年12月舊的升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	是	醫(yī)學(xué)	1區(qū)	ENDOCRINOLOGY & METABOLISM 內(nèi)分泌學(xué)與代謝	2區(qū)

Obesity Reviews JCR評價數(shù)據(jù)（2023-2024年最新版）

按JIF指標學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：ENDOCRINOLOGY & METABOLISM	SCIE	Q1	14 / 186	92.7%

按JCI指標學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：ENDOCRINOLOGY & METABOLISM	SCIE	Q1	20 / 186	89.52%

Obesity Reviews歷年數(shù)據(jù)統(tǒng)計

影響因子

中科院分區(qū)

Obesity Reviews中國學(xué)者發(fā)文選摘

1、Prevalence of anemia and related nutrient deficiencies after sleeve gastrectomy: A systematic review and meta-analysis
Author: Nie, Yuntao; Tian, Ziru; Wang, Pengpeng; Liu, Baoyin; Zhang, Nianrong; Zhou, Biao; Wang, Siqi; Hei, Xiaofan; Meng, Hua

Journal: OBESITY REVIEWS. 2023; Vol. 24, Issue 1, pp. -. DOI: 10.1111/obr.13516
2、Regulatory role of atrial natriuretic peptide in brown adipose tissue: A narrative review
Author: Lu, Guanhua; Hu, Ruixiang; Tao, Tian; Hu, Min; Dong, Zhiyong; Wang, Cunchuan

Journal: OBESITY REVIEWS. 2023; Vol. 24, Issue 1, pp. -. DOI: 10.1111/obr.13522
3、Two-sided roles of adipose tissue: Rethinking the obesity paradox in various human diseases from a new perspective
Author: Pan, Jing; Yin, Jianqiong; Gan, Lu; Xue, Jianxin

Journal: OBESITY REVIEWS. 2023; Vol. 24, Issue 1, pp. -. DOI: 10.1111/obr.13521
4、Deciphering the obesity paradox in the elderly: A systematic review and meta-analysis of sarcopenic obesity
Author: Liu, Chaoran; Wong, Pui Yan; Chung, Yik Lok; Chow, Simon Kwoon-Ho; Cheung, Wing Hoi; Law, Sheung Wai; Chan, Juliana Chung Ngor; Wong, Ronald Man Yeung

Journal: OBESITY REVIEWS. 2023; Vol. 24, Issue 2, pp. -. DOI: 10.1111/obr.13534
5、Association of fast-food restaurants with overweight and obesity in school-aged children and adolescents: A systematic review and meta-analysis
Author: Jiang, Jun; Lau, Patrick W. C.; Li, Yanhui; Gao, Di; Chen, Li; Chen, Manman; Ma, Ying; Ma, Tao; Ma, Qi; Zhang, Yi; Liu, Jieyu; Wang, Xingxing; Dong, Yanhui; Song, Yi; Ma, Jun

Journal: OBESITY REVIEWS. 2023; Vol. 24, Issue 3, pp. -. DOI: 10.1111/obr.13536
6、Fine particulate matter induces adipose tissue expansion and weight gain: Pathophysiology
Author: Della Guardia, Lucio; Wang, Ling

Journal: OBESITY REVIEWS. 2023; Vol. 24, Issue 4, pp. -. DOI: 10.1111/obr.13552
7、Maternal obesity and offspring health: Adapting metabolic changes through autophagy and mitophagy
Author: Wang, Litao; O'Kane, Aislinn M. M.; Zhang, Yingmei; Ren, Jun

Journal: OBESITY REVIEWS. 2023; Vol. , Issue , pp. -. DOI: 10.1111/obr.13567
8、Is metformin still the most efficacious first-line oral hypoglycaemic drug in treating type 2 diabetes? A network meta-analysis of randomized controlled trials.
Author: Jia Y¹, Lao Y¹, Zhu H¹, Li N¹, Leung SW^1,².

Journal: Obes Rev. 2019 Jan;20(1):1-12. doi: 10.1111/obr.12753. Epub 2018 Sep 17.